Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Hypercholesterolemia Drugs > Flashcards

Hypercholesterolemia Drugs Flashcards

1
Q

Which cholesterols cause and inhibit hyperlipidemia?

A

LDL promotes hyperlipidemia. HDL inhibits hyperlipidemia. Triglycerides promote hyperlipidemia in an unclear way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the “good” and “bad” cholesterols?

A 
LDL = bad (Lousy)
HDL = good (Happy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the basic structure of an LDL

A

Spherical shape.
Phospholipids and cholesterol on the outside along with apoprotein B100. On the inside of the sphere, there are triglycerides and cholesterol esters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What enzyme cleaves fatty acids from chylomicrons in the bloodstream?

A

Lipoprotein Lipase (LPL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where are released fatty acids taken up?

A

Free fatty acids taken up by adipose tissue (storage) or by muscle (energy production through Beta-oxidation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the very basic mechanism of atherosclerosis as caused by hyperlipidemia

A

High LDL infiltrates the vessel wall, leading to development of an atheroma (fatty streak) to cause atherosclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens to the LDLs when they enter the intima?

A

They get oxidized.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the oxidation of LDLs cause?

A

Upregulation of adhesion molecules on the endothelium, leading to monocyte infiltration of the intima

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When macrophages swallow LDL, they become….

A

Foam cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do foam cells function?

A

Secrete growth factors and ECM components. Allows medial smooth muscle to infiltrate into the intima through the IEL. Forms an artherosclerotic plaque!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the protective functions of HDL in prevention of atherosclerosis

A

Inhibits oxidation of LDLs (PON1 on HDLs has antioxidant activity)

Inhibit adhesion molecule expression on endothelium

Inhibit foam cell formation

Promotes reverse cholesterol transport (from the periphery to the liver to be secreted as bile)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List some causes of Hyperlipidemia

A 
Genetics (Familial Hyperlipidemia -- defect in LDL receptor)
High fat/carb diet
Age
Physical inactivity
Alcohol consumption
Smoking
Diabetes
Drugs (HIV antiviral proteases, antipsychotics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the ideal serum level of LDL?

A

Less than 100mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a very high serum LDL level?

A

> 190 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is an ideal serum triglyceride level?

A

Less than 150mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a very high serum triglyceride level?

A

> 500 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Very high serum triglyceride levels increase a patient’s risk of developing…

A

Pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the principal goal of treatment for hypercholesterolemia?

A

Reduce serum LDL levels to hopefully reduce risk of cardiovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Statins inhibit what enzyme? What does this accomplish?

A

HMG CoA Reductase

Reduction of serum LDLs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe the mechanism by which statins lower LDL levels

A

Bind HMG CoA reductase and competitively inhibit it. Triggers a signaling pathway that activates SREBP transcription factor to upregulate LDL receptors in cells. Increase LDL uptake from the serum, therefore decreasing serum levels. The LDL’s cholesterol can be excreted in bile

21
Q

What are some other anti-atherogenic effects of statins?

A
  • Inhibit adhesion molecules on the endothelium.
  • Inhibit foam cell production.
  • Inhibit smooth muscle proliferation.
  • Anti-inflammatory
22
Q

Does a statin’s ability to decrease CV disease risk depend on LDL levels?

A

No! Statins decrease risk of CV diseases even in patients with normal LDL levels.

23
Q

Does increasing the dose of a statin generally cause a greater reduction in LDL?

A

Not really. Increasing the dose doesn’t have much effect in reducing LDLs, but increased statin dose increases risk of adverse effects

24
Q

Adverse Effects of Statins

A

Generally well tolerated.

  • Mild GI disturbance
  • Increase liver enzymes
  • Increase risk of T2DM
  • Myalgia/Myopathy
  • Rhabdomyolysis
25
Q

Rhabdomyolysis

What is it? Describe the basic mechanism by which statins can cause it

A

Inflammation of the muscle followed by disintegration

High levels of statins in the blood allow statins to enter muscles. Cause muscle breakdown, myoglobulin release, kidney damage!

26
Q

Which statin has a lower risk of developing rhabdomyolysis?

A

Pravastatin

27
Q

Statins

Absorption

A

Well absorbed orally

28
Q

Statins

Metabolism

A

Lovastatin, Simvastatin, Atorvastatin are all metabolized by CYP3A4 in the intestine.

Fluvastatin metabolized by CYP2C9

Rosuvastatin metabolized by CYP2C19

Pravastatin is not metabolized by CYP450 enzymes.

29
Q

Statins

Elimination

A

Primarily Hepatic, but Pravastatin is both hepatic and renal

30
Q

Describe potential effects of grapefruit juice with statins

A

Grapefruit juice inhibits CYP3A4, causing increased serum statin levels, which could cause rhabdomyolysis

31
Q

List some inducers of CYP3A4 and their potential effects when taken with statin.

A

Phenytoin, Barbiturates, rifampin are inducers of CYP3A4.

Could decrease clinical efficacy of lovastatin, atorvastatin, and simvastatin

32
Q

Statins are transported into hepatocytes via what transporter?

A

OATP2

33
Q

Gemfibrozil has what effects when taken with statins?

A

May increase serum concentrations of statins, leading to potential toxicity.

  • Competes with statins for OATP2
  • Prevent glucoronidation of statins in their metabolism
34
Q

Statins

Contraindications

A

Pregnant women and nursing mothers (this may change)

Patients with liver disease (except Pravastatin)

35
Q

List the Bile Acid Binding Resins

A

Cholestyramine
Colestipol
Colesevelam

36
Q

MOA Bild Acid binding Resins

A

The resins are cationic polymers that can bind negative bile acids. Form an insoluble complex that is excreted into feces. Less recycling of bile acids.

Liver produces more bile acids in response through activation of cholesterol-7-alpha-hydroxylase. Increased LDLR expression on surface, increased uptake of LDL, lower serum LDL

37
Q

Bile acid binding resins may decrease LDL levels in serum, but what else do they affect?

A

May increase serum triglycerides

Could cause pancreatitis if triglycerides >500mg/dL

38
Q

Bile Acid Resins

Therapeutic Uses

A

Reduce LDL in bloodstream and risk of CV events.

Second line agents that may be used in combination with statins

39
Q

Bile Acid Resins

Adverse Effects

A

NOT absorbed or metabolized, so few adverse effects. Minor GI disturbances.

May impair absorption of many drugs (especially anions), so take doses at separate times.

40
Q

Bile Acid Resins

Contraindications

A

Increased triglyceride levels (could cause pancreatitis)

41
Q

Ezetimibe

MOA

A

Impairs cholesterol absorption from intestine. Inhibits NPC1L1 to lower flux of cholesterol going to the liver, which will increase levels of LDLR expression and increase LDL clearance.

42
Q

Ezetimibe

Therapeutic Uses

A

May be used in combination with a statin.

Active in patients with familial hypercholesterolemia.

43
Q

PCSK9 Inhibitors

Describe their function.

A

Prevent internalization and degradation of LDLR, thus increasing LDL uptake into liver and lowering serum levels.

44
Q

List the PCSK9 inhibitors

A

Alirocumab
Evolocumab
(Both antibodies administered IV)

45
Q

PCSK9 Inhibitors

Therapeutic Uses

A

Lower serum LDL levels.

Used in patients with heterozygous FH and patients that have not achieved goals with max tolerated statins

46
Q

What are the two drugs used in treatment of homozygous familial hypercholesterolemia?

A

Lomitapide

Mipomersen

47
Q

Lomitamide

MOA

A

Inhibits MTP in enterocytes and liver.

Less formation of chylomicrons and VLDLs, less LDL

48
Q

Mipomersen

MOA

A

Antisense oligonucleotide for poB100

Inhibits structural components of VLDLs and chylomicrons to prevent LDL synthesis

Pharmacology (67 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions